ZA200602416B - Non-tabletted, chewable, individually dosed administration forms - Google Patents

Non-tabletted, chewable, individually dosed administration forms

Info

Publication number
ZA200602416B
ZA200602416B ZA200602416A ZA200602416A ZA200602416B ZA 200602416 B ZA200602416 B ZA 200602416B ZA 200602416 A ZA200602416 A ZA 200602416A ZA 200602416 A ZA200602416 A ZA 200602416A ZA 200602416 B ZA200602416 B ZA 200602416B
Authority
ZA
South Africa
Prior art keywords
tabletted
chewable
administration forms
dosed administration
individually dosed
Prior art date
Application number
ZA200602416A
Other languages
English (en)
Inventor
Fabregas Vidal Jose Luis
Masso Carbonell Antoni
Garcia Gonzalez Nuria
Original Assignee
Almirall Lab
Patent Dept Almirall Prodesfar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34610359&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200602416(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Lab, Patent Dept Almirall Prodesfar filed Critical Almirall Lab
Publication of ZA200602416B publication Critical patent/ZA200602416B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200602416A 2003-11-10 2006-03-24 Non-tabletted, chewable, individually dosed administration forms ZA200602416B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200302612A ES2235626B1 (es) 2003-11-10 2003-11-10 Formas de administracion masticables, no comprimidas dosificadas individualmente.

Publications (1)

Publication Number Publication Date
ZA200602416B true ZA200602416B (en) 2009-06-24

Family

ID=34610359

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200602416A ZA200602416B (en) 2003-11-10 2006-03-24 Non-tabletted, chewable, individually dosed administration forms

Country Status (25)

Country Link
US (1) US20070134318A1 (de)
EP (1) EP1682097B1 (de)
JP (1) JP4879021B2 (de)
KR (1) KR20060116821A (de)
CN (1) CN1878542A (de)
AR (1) AR048050A1 (de)
AT (1) ATE492270T1 (de)
AU (1) AU2004290517B2 (de)
BR (1) BRPI0416215A (de)
CA (1) CA2548615A1 (de)
CO (1) CO5690531A2 (de)
DE (1) DE602004030706D1 (de)
EC (1) ECSP066553A (de)
ES (2) ES2235626B1 (de)
IL (1) IL175285A (de)
MY (1) MY143793A (de)
NO (1) NO20062723L (de)
NZ (1) NZ546375A (de)
PE (1) PE20050488A1 (de)
RU (1) RU2369379C2 (de)
TW (1) TW200526266A (de)
UA (1) UA90253C2 (de)
UY (1) UY28586A1 (de)
WO (2) WO2005048975A1 (de)
ZA (1) ZA200602416B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US8993593B2 (en) 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
PT2061465E (pt) 2006-08-23 2013-07-15 Valeant Pharmaceuticals Int Derivados de 4-(n-azacicloalquil)anilidas como moduladores do canal de potássio
US8030518B2 (en) 2006-11-28 2011-10-04 Valeant Pharmaceuticals International 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
US8367684B2 (en) 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
JP5269894B2 (ja) * 2007-06-27 2013-08-21 ハンミ ファーム． シーオー．， エルティーディー． 経口投与用速溶性製剤の製造方法及びその製造、並びに包装装置
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
US7786146B2 (en) 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
EP2238976B1 (de) * 2009-04-03 2012-06-27 Hexal AG Oraler Film mit 7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-chinolin-2-on-Base oder Salze oder Hydrate davon
NZ597319A (en) 2009-06-25 2014-06-27 Alcobra Ltd A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
EA021368B1 (ru) * 2011-06-21 2015-06-30 Общество С Ограниченной Ответственностью "Консорциум-Пик" Препарат кардиопротекторного действия
CN105911057B (zh) * 2016-06-22 2018-10-19 扬州一洋制药有限公司 一种铝镁加混悬液的质量控制方法
CN113425694A (zh) * 2021-07-02 2021-09-24 杭州蚕宝生物技术有限公司 一种石斛生物碱口腔崩解片剂及其制备方法
US12053484B2 (en) 2021-10-29 2024-08-06 Medicated Chews, Llc Simethicone chewable composition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5645411A (en) * 1979-09-20 1981-04-25 Taiho Yakuhin Kogyo Kk Poultice
FR2515035A1 (fr) * 1981-10-26 1983-04-29 Rhone Poulenc Sante Nouvelle forme galenique solide pour administration par voie orale et son procede de fabrication
EP0409432A3 (en) * 1989-07-20 1991-12-11 Warner-Lambert Company Confectionery delivery system
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JPH0912463A (ja) * 1995-06-23 1997-01-14 Fujisawa Pharmaceut Co Ltd 口中咀嚼用製剤
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6060078A (en) * 1998-09-28 2000-05-09 Sae Han Pharm Co., Ltd. Chewable tablet and process for preparation thereof
US6652880B1 (en) * 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
WO2002064109A2 (en) * 2001-02-14 2002-08-22 Gw Pharma Limited Mucoadhesive pharmaceutical formulations
US6692771B2 (en) * 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration

Also Published As

Publication number Publication date
AU2004290517A1 (en) 2005-06-02
ECSP066553A (es) 2006-12-20
NZ546375A (en) 2009-11-27
WO2005048974A3 (en) 2006-02-23
TW200526266A (en) 2005-08-16
ES2358332T3 (es) 2011-05-09
IL175285A (en) 2011-04-28
US20070134318A1 (en) 2007-06-14
WO2005048975A1 (en) 2005-06-02
ES2235626B1 (es) 2006-11-01
MY143793A (en) 2011-07-15
BRPI0416215A (pt) 2006-12-26
JP2007510690A (ja) 2007-04-26
ATE492270T1 (de) 2011-01-15
NO20062723L (no) 2006-06-12
AU2004290517B2 (en) 2010-05-27
CA2548615A1 (en) 2005-06-02
JP4879021B2 (ja) 2012-02-15
RU2369379C2 (ru) 2009-10-10
PE20050488A1 (es) 2005-08-24
WO2005048974A2 (en) 2005-06-02
EP1682097A2 (de) 2006-07-26
RU2006120087A (ru) 2007-12-27
CO5690531A2 (es) 2006-10-31
UY28586A1 (es) 2005-05-31
EP1682097B1 (de) 2010-12-22
CN1878542A (zh) 2006-12-13
IL175285A0 (en) 2006-09-05
UA90253C2 (ru) 2010-04-26
ES2235626A1 (es) 2005-07-01
AR048050A1 (es) 2006-03-29
DE602004030706D1 (de) 2011-02-03
KR20060116821A (ko) 2006-11-15

Similar Documents

Publication Publication Date Title
IL175285A0 (en) Non-tabletted, chewable, individually dosed administration forms
EG25273A (en) Substituted dihydroquinazolines.
ZA200408173B (en) Toothbrush.
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
DK1765303T3 (da) Misbrugsikret, oral dispenseringsform
HK1086012A1 (en) 8-substitued-6,7,8,9-tetrahydropyrimidoÄ1,2-aÜ pyrimidin-4-one derivatives
ZA200506744B (en) PyrazoloÄ1,5-AÜpyrimidine derivatives
PL1615640T3 (pl) Kombinacje przeciwnowotworowe
HK1092715A1 (en) Melt-formulated, multi-particulate oral dosage form
GB0314733D0 (en) Medicaments
GB0308968D0 (en) Medicaments
GB0408321D0 (en) Multiple protocol database
GB2401043B (en) Drug
ZA200408787B (en) Pharmaceutical combination.
MX258179B (es) Poliamidas.
EP1711189A4 (de) 6,11-3c-bicyclische 8a-azalid-derivate
LU91022B1 (en) Sektionaltor.
AP2006003501A0 (en) Supplement preparation.
GB0315019D0 (en) Dosage form
EP1624073A4 (de) Arzneistoff
ZA200402034B (en) A pharmaceutical composition.
GB0315045D0 (en) Dual.L
TJ391B (en) Medicinal-preventive biopreparation subtilben.
ZA200300393B (en) Temporary structure.
GB0329859D0 (en) Medicaments